Azithromycin tablets/capsules 250 mg; azithromycin tablets/capsules 500 mg; azithromycin, powder for oral suspension, 200 mg/5 ml, 15 ml (600 mg suspension); amikacin, solution for injection, 250 mg/ml 2 ml; amoxicillin tablets/dispersible...
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
Azithromycin tablets/capsules 250 mg; azithromycin tablets/capsules 500 mg; azithromycin, powder for oral suspension, 200 mg/5 ml, 15 ml (600 mg suspension); amikacin, solution for injection, 250 mg/ml 2 ml; amoxicillin tablets/dispersible tablets 500 mg; ibuprofen solution for infusion 4 mg/ml 100 ml; atropine sulfate solution for injection 1 mg/1 ml, in 1 ml ampoule; sulfamethoxazole/trimethoprim tablets 400 mg/80 mg; ibuprofen, oral suspension, 100 mg/5 ml, 100 ml; gentamicin, solution for injection, 40 mg/ml, 2 ml; sodium heparin, solution for injection, 5000 IU/ml, 5 ml; hydrocortisone, suspension for injection, 25 mg/ml, 2 ml; insulin glulisine, solution for injection, 100 IU/ml, 3 ml; ibuprofen tablets/capsules 200 mg; imipenem/cilastatin 500 mg/500 mg powder for solution for infusion; clarithromycin film-coated tablets 500 mg; insulin glargine, solution for injection, 100 IU/ml, 3 ml; insulin detemir, solution for injection, 100 IU/ml, 3 ml; amoxicillin/clavulanic acid powder for oral suspension 400 mg/57 mg in 5 ml, 70 ml vial; meropenem, powder for injection/infusion, 1 g; meropenem, powder for injection 0.5 g; methylprednisolone, powder and solvent for solution for injection, 500 mg; naloxone solution for injection, 0.4 mg/ml 1 ml; insulin aspart (rapid-acting), solution for injection, 100 IU/ml, 3 ml; paracetamol tablets/capsules 500 mg; paracetamol tablets/capsules 200 mg; cefepime, powder for injection 1.0; prednisolone, solution for injection, 30 mg/ml, 1 ml; hydrocortisone, powder and solvent for solution, 100 mg; cefixime tablets/capsules 400 mg; insulin glargine, solution for injection, 300 IU/ml, 1.5 ml; insulin degludec, solution for injection, 100 IU/ml, 3 ml; ceftazidime, powder for injection 1.0 g; ciprofloxacin film-coated tablets 500 mg; ciprofloxacin film-coated tablets 250 mg; ciprofloxacin, eye/ear drops, 3 mg/ml, 5 ml; ofloxacin eye drops 3 mg/ml 5 ml vial
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Healthcare and Medicine, Chemicals